The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies by unknown
The use ofmAbs to surface antigens has identified several molecules, other than
theTCR-CD3 complex and peptide-presenting MHC products, which contribute
to the interaction ofAPC andTlymphocytes. Most notable are mAbs against CD4
and CD8 (1, 2), andlymphocyte function-associated antigen 1 (CDlla, LFA-1)t (3)
and its ligand, intercellular adhesion molecule 1 (CD54, ICAM-1) (4) . Each mAb
inhibits antigen-driven T cell proliferation when antigen is presented by a variety
ofAPC, including one of the most potent, dendritic cells (5).
An early step in aprimaryimmune response is theassociation ofTcells andAPC
in discrete, long-lived (days), aggregates (6, 7) . However, none of the known mole-
cules on eitherT cells or dendritic cells appears essential fortheearly stages of cluster
formation in mice, primarily because rat mAbs directed against these molecules do
notblockthe formation ofsizeable aggregates in the murine MLR (5) . Forexample,
mAbs to LFA-1 inhibit the binding between T cells and activated B cells but fail
to inhibit initial dendriticT cell clustering (8).
Recently, when the rat has proved to bea difficult host for preparingmAb to struc-
turally conserved murine molecules, several investigators have used Armenianham-
sters as ahost (9-11) . We adopted a similar approach to search for mAbs that would
inhibit dendriticT cell clustering or would bind to dendritic cells in a novel assay
using the FACS . We report here the isolation of two newanti-mouse leukocyte inte-
grin mAbs : 2E6, which recognizes a determinant common to all members of the
02 integrin family and N418, which identifies a distinct p150,90 member ofthe family,
possibly CDllc . Using these new reagents, we describe the distinct expression and
function of leukocyte integrins on spleen dendritic cells .
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Materials and Methods
BALB/C x DBA/2 F, [CxD2 F,, H-2d], C57B1/6 x DBA/2 F, [B6xD2 F,, H-26xd], and
C3H/He [H-2k] mice of both sexes, from the Trudeau Institute (Saranac, NY), were used
at 8-12 wk of age. Adult female Armenian hamsters [C. migratorious] were purchased from
Cytogen Research and Development (Cambridge, MA) .
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Culture Medium
RPMI 1640 (Gibco Laboratories, Grand Island, NY) was supplemented with 20 ug/ml
gentamicin, 5 x 10-5 M 2-ME, and 100 1o heat-inactivated FCS (R10; Hazelton, Lenexa, KS),
and used for maintaining hybridomas and primary cell cultures. For selecting hybridomas,
DMEM with high glucose (Gibco Laboratories) was supplemented with 20% FCS, HAT,
2-ME, and antibiotics (HAT medium).
Cell Populations
Murine spleen dendritic cells were prepared by amultistep technique (12). Briefly, spleens
were sequentially digested with collagenase, floated on dense BSA, adhered to tissue culture
plastic, washed free of nonadherent cells, cultured overnight, and depleted ofcontaminating
FcR' B cells and macrophages by rosettingwith antibody-coated sheep RBC. The dendritic
cells were routinely >95% pure as judged by FACS analysis (Results) (8, 12).
Bcellswere purified from spleen suspensions by depletingdendriticcellsandmacrophages
by passageover columns of Sephadex G10 (Pharmacia Fine Chemicals, Piscataway, NJ), and
then depletingT cellsby treatmentwith acocktail ofanti-T cell reagents (anti-Ly-1, antiThy-
1, anti-Ly-2) and rabbit complement (Pel-Freez Biologicals, Rogers, AR). Activated B cells
were prepared by culturingpurified B cellswith polyclonal goat anti-mouse Ig (Jackson Im-
munoresearch, West Grove, PA)coupled to CNBr-activated Sepharose(Pharmacia Fine Chem-
icals) at 5 Wg/ml for 2-3 d. The anti-Ig blasts were enriched on Ficoll-Hypaque gradients
(Pharmacia), and shown to be >95% B blasts with similar levels of class II MHC products
to dendritic cells (8).
CD4' T cells were nylon wool nonadherent, mesenteric lymph node cells that had been
treated with anti-Ia and anti-Ly-2 mAbs plus complement to deplete accessory cells and
CD8' T cells.
Peritoneal exudate cells were harvested from mice 4 d after an injection of 1-1.5 ml i.p.
of thioglycolate (Difco Laboratories, Detroit, MI).
Immunization and Fusion
Two fusions were performed using hamster spleen cells that had been primed to mouse
spleen dendritic cells. In the first, which yielded the 2E6 anti-CD18 reagent, 5 x 106 den-
dritic cells were given intraperitoneally on day -41 and -3 before fusing. In the second,
which yielded the N418 anti p150,90 and N22 anti-MHC class II mAb, the hamsters were
primed with 5 x 106 dendritic cells intraperitoneally on day -220 and boosted with 1.3 x
106 cells intraperitoneally on day -10 and 5 x 106 cells intracardiac on day -3.
Forboth fusions, on day 0the SP 2/0 myeloma cells were mixed with hamster spleen cells
at aratioof 1:4 and fusedwith 50% (wt/vol) polyethylene glycol for90 s. Afterslowly diluting
the fusion mixture with a total of 15 ml of warm medium over a total of 8 min, the cells
were either further diluted in HAT medium (clones N418, N22) for direct plating or were
first centrifuged and then gently resuspended in HAT medium forplating (clone 2E6). 2-3 x
104 myeloma cells were plated per well in 96-well flat-bottomed plates (microwells; Corning
GlassWorks, Corning, NY). Thewells were fed two to four times over a3-wk period before
screening the culture supernatants.
Hybridoma Screening
Threeassays were used to select hybridomas ofinterest. (a)To test if thehybridomasuper-
natant (25°Jo vol/vol) would inhibit the formationof dendritic-T cell clusters in the primary
MLR, 3 x 104 dendritic cells and 3 x 105 allogeneic T cellswere cultured in flat-bottomed
microtestwells and clustering was assessed at 24 h by microscopic observation. (b) Superna-
tant was addedto a cryostat sectionof spleen followed by labeling with aperoxidase (POX)-
conjugated anti-hamster Ig (in the presence of 1% mouse serum) or with biotin-RG7 plus
avidin-biotin-peroxidase complexes(see below). (c) Selectivebindingto spleen dendritic cells
was evaluated with a new FACS approach. Purified dendritic cells were labeled with FITC
(2 pg/ml 20 min) as described (13) and mixed with unlabeled mesenteric lymph node cells
at a ratio of 1:10. 105 cells of the mixture were added to round-bottomed wells containing
100 Al of hybridomaculture supernatant. Bound mAbs were detected with anti-hamster Igand a PE-label (see below), so that two-color FAGS analysis would identify mAbs that stained
dendritic cells (positive in both FITC and PE channels) but not the other leukocytes (negative
in both channels).
Hybridoma Cloning
Hybridomas were cloned by limiting dilution (14). Wells positive for hybridoma growth
were rescreened for staining of spleen sections (see Results). The 2E6 anti-CD18 cells have
been stable secretors, but the N418 anti-CDllc line has required periodic recloning to pre-
vent overgrowth by nonsecreting clones.
FACS Staining
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105 to 5 x 105 cells per sample were stained in round-bottomed muldwell plates. Washing
was carried out by centrifuging the plates two to three times between staining steps with PBS
containing 1176 BSA and 0.02 % NaN3 . Binding ofhamster mAbs was visualized with a three-
step technique involving hybridoma supernatants, biotinylated mouse anti-rat Kchain (mAb
RG7/7.6, at 2-3 Rg/ml) that crossreacts with Armenian hamster K chains (15), and PE-strep-
tavidin (Biomedia Corp., Foster City,CA; 3 jig/ml). Alternatively, the hamster mAb was stained
with a FITC or biotin conjugate of a goat anti-hamster Ig (Vector Laboratories, Burlingame,
CA). Binding of rat mAbs used a two-step technique in which the second reagent was
FITC-mouse anti-rat Ig (Boehringer-Mannheim Biochemicals, Indianapolis, IN; 3 ttg/ml).
All samples were analyzed on a FACScan (Becton-Dickinson, Mountain View, CA).
Production, Purification, and Modification of mAbs
Rat mAbs RA3-6B2.1 (anti-B220), F4/80 (anti-macrophage), Ml/70 (anti-CD llb/CR3),
FD441.8 (anti-CDlla/LFA-1), B21.2 (anti-I-Ab,d), GK1 .5 (anti-CD4), and 3 .155 (anti-
CD8/Lyt-2) were all grown in our laboratory and used as culture supernatants for staining
and blocking experiments (16). Hamster mAbs, in addition to the new reagents described
here, included 2C11 (anti-CD3)(10) and S4B6.1 (anti-murine IL-2) (11), which were provided
by Drs. J . Bluestone (University of Chicago, Chicago, IL) and T. Mossman (DNAX Re-
search Institute, Palo Alto, CA) and maintained in our lab. For Ig purification from many
hybridomas (2E6, M1/70, and FD441.8), cells were grown to maximal density in serum-free
medium (Nutridoma-SP, Boehringer-Mannheim), and the mAb was precipitated with 50%
saturated [NH4]2SO4 for 2 h at 4°C. This technique provided Ig of high purity as judged
by Coomassie staining on SDS-PAGE. For purification of mAb RG7/7.6 (17), ascites that
had been precipitated with [NH4]2504 (kindly provided by M. Birkeland and E. Pure), was
further purified by protein A chromatography. The N418 Ig was purified from hybridoma
culture supernatant using a protein A column (Pierce Chemical Co., Rockford, IL).
Purified mAbs were coupled to CNBr-activated Sepharose (Pharmacies Fine Chemicals)
at a ratioof 2 mg/ml packed beads as per manufacturers instructions. Purified RG7/7 .6 was
coupled with biotin-N-hydroxysuccinimide (Zymed Laboratories, San Francisco, CA) at a
weight ratio of 1 :1 and then dialyzed extensively against PD (PBS without Cat' or Mgt+).
An F(ab')2 fragment of 2E6.1 was generated by incubating 5 mg purified mAb with 0.5
ml pepsin gel (Pierce Chemical Co.), as per manufacturer's instructions, for 4 h at 37°C with
constant agitation. Undigested molecules were subsequently removed by passage over im-
mobilized protein A columns. The F(ab')2 fragment was judged free of contaminating in-
tact IgG by analysis on SDS-PAGE and Coomassie staining.
Immunoprecipitation
1 .5-3 x 10' cells were washed two times in RPMI and one time in PD with 1 mg/ml glu-
cose. Cells were resuspended in 1 ml ofthe latter buffer and iodinated by the sequential addi-
tion of glucose (to 20 mM), 3 mCi 1251 (Na1211; New England Nuclear, Boston, MA) 20 wg
LPO, and glucose oxidase (18). After 15 min on ice, cells were washed three times and then
lysed on ice with buffer containing 1% NP-40, 1% aprotinin, 1 mM PMSF, and 1 mM DFP
(added fresh) for 10 min. Cell debris and nuclei were pelleted at 10,000 rpm for 10 min. 0.5-1 x
10' cpm were precipitated per sample afterfirst preclearing the lysate three times with normal
rat Ig and RG7-Sepharose, or rat Ig coupled directly to Sepharose. Samples were precipi-1756
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tated either directly with an equal volume of antibody coupled to Sepharose or indirectly
with equal volumes of antibody supernatant followed by RG7-Sepharose. After incubating
at 4'C with shaking, Sepharose pellets were washed two times with PD, once with high salt
azide (HSA, 0.6 M NaCl, 0.0125 M KP04, 0.02% NaN3, pH 7.4), once with mixed deter-
gent buffer (0.05% NP-40, 0.1% SDS, 0.3 M NaCl, 10 mM Tris pH 8.6), once with HSA,
and twice with PD. Pellets were resuspended in 2x sample buffer (2 ° Jo SDS, 1017o glycerol,
80 mM Tris pH 6.8, with bromophenol blue), boiled, and subjected to SDS-PAGE and auto-
radiography with enhancing screens.
Immunocytochemistry
Fresh tissue was embedded in OCT (Miles Inc., Elkhart, IN) and 10-Am-thick sections
were applied to 10-well slides (Carlson Scientific Inc., Peotone, IL). Slides were fixed in ace-
tone (10 min, RT) and stained by the sequential addition ofprimary mAb supernatant, biotin-
RG7/7.6, avidin-biotin-peroxidase complex (Vectastain ABC kit; Vector Laboratories, Inc.),
and 3,3'-diaminobenzidine tetrahydrochloride (Polysciences, Inc., Warrington, PA) (19). Slides
were mounted in PD-glycerol for photography.
Functional Effects of mAbs on Leukocyte Integrin Function
C3bi Binding.
￿
Terasaki microwells were coated with 20% FCS in PBS and then elicited
peritoneal cells were applied (5 p.l/well at 106/ml in PBS with 1% BSA) for 40 min at 37°C .
After washing, hybridoma culture supernatants were added to the wells for 10 min on ice.
Then sheep RBC coated with C3bi (20) were applied (5 pl/well at 108/ml) and incubated
for 10 min on ice plus a further 30 min at 37'C. The plates were washed by gently swirling
and inverting in PBS, and fixedwith 2.5 % glutaraldehyde for scoring. The attachment index
was the total number of attached RBC per number of macrophages counted x 100.
Homoypic Clustering .
￿
This assay was performed according to Rothlein and Springer (21).
Anti-Ig-activated B cells were added to 96-well flat-bottomed plates with 50 ng/mlPMA (Sigma
Chemical Co., St. Louis, MO). mAbs were added at 25% vol/vol. The cultures were moni-
tored under an inverted microscope and photographed after 2 h at 37°C.
MLR Clustering andProliferation.
￿
Purified dendritic cells or B blasts, irradiated with 1,500 rad
' 37Cs, were added in graded doses to 3 x 105 CD4', allogeneic T cells in 96-well plates (8).
Purified mAb or hybridoma culture supernatant was added at the start of the MLR. The
cultures were photographed at 24 h of culture. 1 uCi/well [3H]TdR was added for the last
8 h as noted. The wells were harvested with a Skatron automatic harvester (Skatron, Inc.,
Sterling, VA) to be counted with a Betaplate scintillation counter (LKB Wallac, Finland).
Results
Selection ofDistinctive HamsterAnti-mouse Leukocyte mAb.
￿
Several approaches were
used to screen hybridomas that were generated from dendritic cell immune, ham-
ster spleen. One approach, the blocking ofdendriticT cell clusteringin the primary
MLR, did not yield a single active mAb from -1,500 wells in two separate fusions .
Another screen, immunolabeling of mouse spleen sections, provided a large number
of reagents that stained in a fashion that had not been noted previously with a large
panel of anti-mouse leukocyte mAb (19). A frequent pattern, exemplified by 2E6,
was reactivity with many cell types in red pulp especially granulocytes, as well as
many cells in white pulp, particularly T cells. 2E6 proved to be an anti-leukocyte
integrin mAb, recognizing a determinant shared by all members of the leukocyte
integrin family (see below). Another frequent immunolabeling pattern was identical
to that seen with standard anti-mouse MHC class II mAb. This also will be illus-
trated below.
A third screening approach involved selective binding to dendritic cells in a two-
color FACS assay. FITC-labeled dendritic cells were mixed at 1 :20 with unlabeledmesenteric lymph node cells, and aliquots of the mixture were exposed to the hy-
bridoma test supernatants. Reactive mAbs were visualized with a biotinylated sec-
ondary reagent followed by PE-streptavidin. The most frequent pattern was a lack
ofreactivity with either FITC labeled or unlabeledcells (Fig. 1 a). Another frequent
pattern was strong reactivity with dendritic cells and a subpopulation of node cells.
In many cases, as exemplified by N22 in Fig. 1 b, these mAb later proved to be
anti-MHC class II by immunoprecipitation and/or by comparison with existing
anti-class II reagents in immunolabeling procedures. The most intriguing pattern,
exemplified by N418 (Fig. 1 c) was clear staining of dendritic but not lymph node
cells. While N418 proved to identify a distinct p150,90 integrin (see below), most
other"dendritic cell specific" candidates proved to react with afine extracellular ma-
trix around blood vessels and scattered about red and white pulp. These were not
pursued further.
Molecular Characterization ofN418 and2E6.
￿
Immunoprecipitation of "'I-labeled
spleen cell lysate with 2E6 revealed apredominant heterodimerof approximate mo-
lecular mass 180, 90 kD, with some minorbands at 150-160 kD (Fig. 2, top left, lane
2). This pattern was reminiscentof thoseimmunoprecipitated by already character-
ized rat mAbs to murine LFA-1 and CR3 (22), and their human counterparts (23).
These molecules are members of a family of leukocyte /32 integrins, each a hetero-
dimer with a distinct a chain (ranging from 180 to 150 kD) but an identicala chain
(90-95 kD). Indeed, the 180, 90 kD heterodimer precipitated by 2E6 comigrated
with bands precipitated by the anti-LFA-1 ct chain mAb (FD441.8). Much less pro-
tein was precipitated from the spleen cell lysate with anti-CR3 cx chain [Ml/70].
This is consistent with the fact that lymphocytes, the majorcell population released
from the spleen, express predominately the LFA-1, CD11a integrin. Sequential im-
munoprecipitation (Fig. 2, top right) proved that 2E6 and anti-LFA-1 identified the
same major heterodimers on spleen cells.
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FIGURE 1.
￿
FACScan profiles representing typicalpatterns ofstaining from screeninghybridoma
supernatants. EA- dendriticcellswere prelabeled with FITC as described andmixedwith bulk
mesenteric lymph node cells at a ratio of 1 dendritic cell to 10 lymph node cells. 1 x 105 cells
were stained per microwell with 100 pl of test hybridoma supernatant. Immunoreactivity was
detected with a 3 layer technique involving biotin-RG7/7.6 followed by PE-streptavidin (see
Methods). Cells were analyzed on a FACScan. Results are presented as single event dot plots
of fluorescence intensity 1 (FITC) vs. fluorescence intensity 2 (PE). The axes span 4 loglo de-
cades. (A)Nonreactive hybridomasupernatant;(B)anti-class II MHC-reactive mAb, N22; (C)
dendritic cell-reactive mAb, N418.1758
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FIGURE 2 .
￿
Immunoprecipitation of 125I-labeled spleen cell lysate and peritoneal macrophage
lysate with anti-integrin mAbs . 3 x 10 7 spleen leukocytes (top) or 2.2 x 10 7 thioglycolate elicited
peritoneal cells (bottom) were labeled with 1251 . Immunoprecipitation ofcell lysates wasperformed
as described in Materials and Methods . Samples were subjected to SDS-PAGE and autoradiog-
raphy . Molecular weights correspond to the positions ofmarker proteins stained with Coomassie
blue . (Left) Primary immunoprecipitation run on6% SDS-PAGE . (Lane 1) Normal rat Ig ; (lane
Z) 2E6; (lane3) Ml/70 (anti-CD11b); (lane 4) FD441.8 (anti-CDlla) . (Right) Sequential immuno-
precipitation ofspleen (top)and peritoneal (bottom) lysates. Samples were precleared with the first
mAb, then precipitated with asecondmAb and runon6% SDS-PAGE . (lane 1) Ml/70 followed
by Ml/70, (lane 2) Ml/70 followed by FD441.8, (lane 3) Ml/70 followed by 2E6, (lane 4) 2E6
followed by Ml/70, (lane 5) 2E6 followed by FD441.8, (lane 6) 2E6 followed by 2E6, (lane 7)
FD441.8 followed byMl/70, (lane 8) FD441.8 followed by FD441.8, (lane 9)FD441.8 followedby 2E6 .METLAY ET AL .
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In contrast, the major integrin on peritoneal macrophages was a 170, 90 kD het-
erodimer precipitated by mAb M1/70 but not by FD441 .8 (Fig. 2, bottom left), as
expected (22) . Again the M1/70 heterodimer comigrated with 2E6, and sequential
immunoprecipitation (Fig. 2, bottom right) confirmedthe identity ofthese twohetero-
dimers . Based on these results, and additional blocking experiments below, we con-
cluded that 2E6 recognizes a determinant common to the LFA-1 (CDlla) andCR3
(CD11b)membersoftheleukocyte /32 integrin family, most likely the commonCD18
(3 chain .
Since mAb 2E6 was raised against spleen dendritic cells and stained these cells
strongly (see below), we performedcomparable studieson iodinated spleen dendritic
cells . 2E6 precipitated LFA-1 andCR3 ot chains from the dendritic cell preparation,
but the predominant species was a 150, 90 kD heterodimer (Fig . 3, lane b) . The
FIGURE 3.
￿
Immunoprecipitation of 1251-labeled spleen dendritic cells with anti-integrin mAbs.
(Lane 1) 7 x 107 EA- spleen dendritic cells were surface labeled with
1251 . Samples were immu-
noprecipitated as described in MaterialsandMethods and subjected to6% SDS-PAGE andau-
toradiography . (Left) LaneT is total surface-labeled dendritic cell lysate . (Middle) Primary im-
munoprecipitations. (a) S4B6 (anti-IL-2) control hamster IgG, (b) 2E6, (c) N418, (d) FD441.8
plus Ml/70 (bothmAbs added simultaneously) . (Right) Sequential immunoprecipitation. Samples
were precleared with the first mAb then immunoprecipitated with the second mAb . (Lane 1)
S4B6 followed by S4B6, (lane 2) S4B6 followed by 2E6, (lane 3) S4B6 followed by N418, (lane
4) 2E6 followed by S4B6, (lane 5) 2E6 followed by 2E6, (lane 6) 2E6 followed by N418, (lane 7)
N418 followed by S4B6, (lane 8) N418 followed by 2E6, (lane 9) N418 followed by N418, (lane
10)FD441.8 + Ml/70 followed by S4B6, (lane 11)FD441.8 + Ml/70 followed by 2E6, (lane 12)
FD441.8 + M1/70 followed by N418 .1760
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150 kD a chain was distinct, since preclearing with anti-LFA-1 and CR3 a chains
eliminated the 180 and 170 kD a chains upon reprecipitation with 2E6, butdid not
remove the 150 kD band (Fig. 3, lane 11). Intriguingly, the bands at 150 and 90
kD are among the major iodinated species on dendritic cells (Fig. 3, lane T).
When themore restricted anti-dendritic cell mAb N418 wastested, the mAbfailed
to precipitate any bands from total spleen lysate (not shown) but precipitated a 150,
90 kD heterodimer from dendritic cell lysate (Fig. 3, lane c). This heterodimer
comigrated with the major bands precipitated by 2E6. Reciprocal preclearing ex-
periments demonstrated that the heterodimers precipitated by 2E6 and N418 were
identical. Since N418 failed to precipitate any of thehigher molecularmass integrin
a chains, we conclude that N418 recognizes the a chain of a 150, 90 kD integrin,
while 2E6 recognizes the common (3 chain.
FACSAnalysis.
￿
Since mAb 2E6 reacted with all members of the leukocyte inte-
grin family, it was not surprising that its cellular distribution was extensive. FAC-
Scan analyses (Fig. 4) showed that 2E6 strongly stained a variety of leukocytes, in-
cluding spleen dendritic cells, activated Bblasts, and peritoneal macrophages. However,
whilelymphocytes and macrophages stained as strongly with 2E6 as with anti-LFA-
1 (lymphoblasts) or anti-CR3 (macrophages), dendritic cells stained more strongly
with 2E6 than with either anti-LFA-1 or anti-CR3 . The N418 mAb, which recog-
nized a third, distinct, /32 integrin, stained the spleen dendritic cells but not the
lymphocytes and macrophages (Fig. 4). As little as 0.1 lcg/ml of Ig provided optimal
staining of dendritic cells, so that antibody was not limiting in these assays. There-
fore the FRCS data again showed that the 150, 90 kD integrin primarily was found
on dendritic cells in the populations we studied.
Immunocytochemistry.
￿
Spleen sections were stained with apanel of mAbs to known
mouse leukocyte antigens (16) to identify the antigens B220 (B cells), CD3/4/8 (T
cells), F4/80 (red pulp macrophages), RB6 (granulocytes), SER4 (marginal zone
macrophages), and B21-2 (MHC class II). ThesemAb, as described before (19, 24),
outlined the B andT cell areas ofthe whitepulp, themarginal zone separating white
and red pulp, and the macrophage/granulocyte-rich red pulp. With these mAbs as
guides, it was noted that 2E6 and N418, the new mAbs to leukocyte integrins, each
stained in a pattern that had not previously been described.
2E6 the presumptive anti-CD18 reagent produced extensive staining of both white
and redpulp (Fig. 5, topright). In the whitepulp, thelymphocytes in the Tdependent
area stained more strongly than in the B area. In the red pulp, both granulocytes
and macrophages were stained. The 2E6 stain was, for the most part, a composite
ofthe stain seen with the CD11a (LFA-1 or F441 .8) and CD11b (CR3 or Ml/70) mAb.
Anti-CD11a stained lymphocytes, particularly T cells around the white pulp central
artery, while Ml/70 stainedgranulocytes in the red pulp, and awebofmacrophages
in the marginal zone (Fig. 5, top).
N418 anti-p150,90 stained the white and red pulp differently from the other anti-
integrin reagents. In the whitepulp, staining wasrestricted to dendriticprofiles within
the T area, with few or no profiles in the B area (Fig. 5, compare bottom left and
right). The N418 stain was different from N22 anti-class II that stained all B cells
in addition to dendritic profiles in the T area (Fig. 5, bottom middle). The staining
by N418 of dendritic cells in the T area was expected, since T areas contain "inter-
digitating cells" that have thecytology andphenotypeofisolated dendritic cells(19, 25).METLAY ET AL.
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FIGURE 4.
￿
FRCS analyses (frequency vs. fluorescence histograms) to demonstrate the distribu-
tion ofleukocyteintegrins on peritonealmacrophages, spleen Bblasts, andspleen dendriticcells.
CxD2 Fl dendriticcells (top), anti-Igblasts (middle), and macrophages (bottom) were stained with
a series ofrat(left) or hamster(right) anti-mouse mAbs. The rat mAbs were Ml/70(anti-CR3),
FD441.8 (anti-LFA-1), andGK1.5 (anti-CD4, control rat IgG).ThesemAbs were visualized with
asecondaryFITC-mouse anti-rat Ig. ThehamstermAbs were 2E6, N418, and 2C11 (anti-CD3,
control hamster Ig), and were visualized with a secondary FITC-rabbit anti-hamster Ig.
In the red pulp [not shown], N418 did not stain granulocytes, but did stain scat-
tered dendritic profiles that were much less numerous than the number of F4/80
positive red pulp macrophages.
In themarginal zone between red and white pulp, N418 produced adistinct staining
pattern. -To interpretthepattern at lowpower(Fig. 6, top), serial sections were stained
with the SER4 mAb (24) to outline the marginal zone macrophages, which were
in turn surrounded by the F4/80+ macrophages of the red pulp as described (19)
(Fig. 6, top). In contrast to most prior descriptions of the marginal zone as a con-
tinuous rim of macrophages, here identified with the SER4 mAb, we found the
marginal zone to be interrupted by regions containing nests of N418+ cells but very1762
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FIGURE 5 .
￿
Immunolabeling ofspleen sections with mAb to leukocyte integrins . Adjacent sec-
tions are shown here . (Top) Comparison ofmAb to CD11a (LEA-1), CDllb (CR3), and CD18
(2E6) . x50 . Each micrograph includes a white pulp nodule (WP), with a central arterial vessel
(black arrowhead) surrounded by red pulp (RP) . The central region of the white pulp contains
aT area (T) surrounded by a B area (B), as evidencedby staining adjacent sections with mAb
to T and B cells (not shown) . Ml/70, anti-CR3 or CDllb stains marginal zone macrophages
at the border of white and red pulp (open arrowheads) and red pulp granulocytes . FD441.8, anti-
LFA-1 or CD11a stains white pulp lymphocytes, particularly T cells around the central artery
(closed arrowhead) . 2E6 anti-CD18 stains the white pulp like anti-CD11a except that the labeling
is less intense . This is because an anti-rat rather than an anti-hamster Ig was used in staining
these sections . 2E6 also stains the red pulp considerably. At higher power, it is evident that both
granulocytes and the network of red pulp macrophages are stained . (Bottom) Immunolabeling
of splenic white pulp with hamster anti-mouse leukocyte mAb . Adjacent sections consisting of
aT area (T) and B area (B) are shown . x200 . (Left) 2C11 anti-CD3 outlines the T cells in the
periarterial sheaths ofthe white pulp . (Middle) N22 anti-MHC class II stains most of the B cells
in the white pulp follicles, and many la-rich dendritic profiles in theT area . (Right) N418 anti-
p150,90 stains theT area, but the pattern is more similar to an anti-la, dendritic cell stain (com-
pare with N22 anti-Ia, middle) than to an anti-T cell stain (compare with 2C11, left) .METLAY ET AL .
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FIGURE 6 .
￿
Identification of nests of N418' presumptive dendritic cells in macrophage-free
regions at the margin of white and red pulp . (Top) Adjacent sections are stained at low power
(x50) to identify N418' cells at the white-red pulp border. F4/80 (left) primarily stains macro-
phages in the red pulp, thereby highlighting five white pulp nodules . SER4 (middle) stains mar-
ginal zone macrophages that lie just internal to the red pulp macrophages . The marginal zone
of four of the five white pulp nodules in the section is punctuated by a macrophage-free region
(arrowheads), which is the major site in which N418 stains (right) . (Bottom) Adjacent sections, at
higher power (x200), ofone of the white-red pulpjunctions depicted with the large closed arrow-
head in the top panels . 2E6anti-CD18 (left) is used here to show a collection of C1318-richT cells
at the white-red pulp junction . This region is not occupied by macrophages, as shown with the
SER4 mAb (middle), but is occupied by densely stained, N418' dendritic cells (right) .
few macrophages that stained for SER4 or F4/80 (Fig. 6) . At higher power, there
was little orno overlap betweenthe cells stained byN418 andthose stained by SER4
(Fig . 6, bottom) and F4/80 (not shown). However, the sections through the N418-
stained areas contained either penetrating arterial vessels and or collections ofT
cells (Fig . 6, bottom) . This pattern [see Discussion] of N418 staining is consistent
with recent observations ofAustyn and colleagues who noted that when dendritic1764
￿
LEUKOCYTE 02 INTEGRINS OF SPLEEN DENDRITIC CELLS
cells were injected intravenously they entered the marginal zone and then homed
into the periarterial Tdependent areas of the white pulp (26).
2E6 Inhibits the Function of Lymphocyte and Macrophage Integrins.
￿
Several cell-cell
binding assays are available that are known to depend on integrin function. The
N418 anti-p150,90 mAb did not show any demonstrable effect in allof the assaysystems
we tested (not shown). Conceivably, the N418 epitope is not close enough to the ac-
tive integrin binding site to influence function. 2E6, however, had marked inhibi-
tory effects in cell-cell binding assays. One such assay involves the homotypic ag-
gregates that develop between activated B lymphocytes; this aggregation is enhanced
after treatment with phorbol esters (21). mAb Ml/70 anti-CD11b failed to inhibit,
but FD441.8 anti-CDlla and 2E6 anti-CD18were completely inhibitory (not shown).
Heterotypic cell aggregates were generated between B blasts and T cells in a pri-
mary MLR (8). Again both mAb FD441.8 and 2E6 strongly blockedbinding, while
mAb M1/70 did not (Fig. 7, bottom). It is to be noted that Fc receptors on B blasts
were not necessary for the inhibition with 2E6, since the F(ab')2 fragment of 2E6
similarlyinhibitedthe B cell-T cell MLR clustering (not shown). In addition, prein-
cubation experiments indicated that the blocking effect of the mAbs was solely due
to the function of LFA-1 on the T cell; i.e., blocking of B blast LFA-1 molecules did
not reduce the MLR clustering but coating the T cells with mAb was inhibitory
(not shown).
Red cells that have been opsonized with the C3bi fragment of the complement
cascade (EC3bi) bind to macrophages. This binding is mediated by the CR3 mole-
cule (27) and is inhibited by the M1/70mAb(28). 2E6inhibited thebindingof EC3bi
to macrophages, consistent with its reactivity with the common integrin (3 chain,
while FD448.1 and control Ig failed to inhibit (not shown). These results, which
are presented in detail elsewhere (29), provided functional evidence that 2E6 recog-
nizes a common leukocyte integrin determinantfound on macrophages, B cells, and
T cells.
Role ofIntegrins in Dendritic Cell Function.
￿
Previous results in our laboratory indi-
catedthat mAbs to CR3 and LFA-1 did not reduce the initial clustering of dendritic
cells and primary T cells at the onset of a cell-mediated immune response. Since
we had identified a thirdintegrin that wasexpressedat high levels on dendritic cells,
we wished to evaluate its contribution to dendritic cell-T cell interactions. N418 anti-
p150,90 did not block dendritic cellT cell binding, but we did not know whether
the N418 mAb bound to an active site on the 150, 90 kD molecule. Since it was
clear from the functional studies on lymphocytes and macrophages that 2E6 mAb
blocked the function of two other integrins, it might therefore be expected to block
the function ofthe 150, 90 kD molecule on dendritic cells. To measure the contribu-
tions of leukocyte integrins in dendritic cell function we recorded the effects of 2E6
and other anti-integrin mAbs both early and late in the primary MLR.
After 24 h of coculture in the MLR, dendritic cells and resting T cells formed
discrete clusters that were readily visible under the inverted microscope. These ag-
gregates were sizeable (5-20 cells in diameter) at 24 h with dendriticT cell ratios
as low as 1 :10 or 1 :30. At a ratio of 1 :3, we repeatedly failed to observe any differ-
ences in the size or frequency of clusters in the presence of any of the test mAbs,
including 2E6 (Fig. 7, top). This failure to observe any inhibition was all the more
striking because, at this same ratio of B blasts to T cells in the MLR, both 2E6
and FD441.8 markedly reduced the clustering (Fig. 7, bottom).METLAY ET AL .
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FIGURE 7 .
￿
(Top) Blocking ofdendritic cell-T cell binding in theMLRwith anti-leukocyte inte-
grin mAbs. 10 5 CxD2 Fl dendritic cells were added to 3 x 105C3H CD4* T cells in microwells
in the presence of25% vol/vol hybridoma supernatants. (Bottom) Blocking of anti-Ig blast-T cell
binding in theMLRwith anti-integrin mAbs . 105CxD2 anti-Ig blasts were added in microwells
to 3 x 10 5 C3H CD4* T cells in the presence of25% vol/volhybridoma supernatants . The cul-
tureswere photographed at 20 h of theMLR at x20 . (a, d) Ml/70, (6, e) FD441.8, (c, f) 2E6 .
As the dendriticTcell ratio waslowered in theMLR, one couldbegin to visualize
a reduction in the size of the clusters at 24 h, particularly in the presence of anti-
LFA-1 (not shown) . This result could indicate that at lower dendritic cell doses, a
ligand for CD11a plays a role in the formation ofAPCT cell contacts . The result
also is consistent with a role for LFA-1 in stabilizing clusters once they are formed,
as previously described (5, 8) . mAbs that block the stabilizing role of LFA-1 in the
clusterwouldbe expected to increase thedissociation rate ofsuch clusters . It follows
that an increased dissociation rate wouldbe visuallymore apparent in those cultures
with smaller clusters, i.e ., those clusters formed at lower numbers of dendritic cells .
As alater measure of integrin function in theMLR, we pulsed the cultures with
[3H]TdR at 72-80 h to assess the level ofDNA synthesis in the T cells . As previ-1766
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￿
Blocking of T cell
proliferation in theMLR with
anti-integrin mAbs. B6xD2 Fl
anti-Ig blasts (right) and den-
dritic cells(left)were cultured in
graded doseswith 3 x 105CxD2
Fl CD4* T cells. At the startof
theMLR, hybridomasuperna-
tants or control R10 medium
were added at 12.5% vol/vol.
Cultures were pulsed from 69
to 77 h.
ously observed (5, 8), anti-LFA-1 inhibited T cell proliferation over the entire dose-
response (Fig. 8). mAb 2E6 also blocked, but less effectively than anti-LFA-1 mAb.
n
Discussion
The Hamsteras a Host to Prepare mAb to Dendritic Cells.
￿
A more thorough analysis
of the tissue distribution and function of dendritic cells has been hampered by the
paucity of cell-restricted mAbs. Ideally, such mAbs would readily label dendritic
cells in tissue sections, aid in their purification from cell suspensions, and help iden-
tify molecules important for the distinct aspects of dendritic cell function.
Previous attempts to raise such mAbs by immunizing rats with murine dendritic
cells have been unsuccessful except forthe 33D1 reagent (30). A majorproblem en-
countered in our experience is the abundance of mAbs to the products of mouse
MHC genes. In one such immunization and fusion, anti-class II MHC mAbs rep-
resented up to 50% of all the positive hybridomas (our unpublished data). Also,
it might be expected that dendritic cell-restricted molecules are conserved among
closely related species. Forthesereasons, the ratmay be a suboptimal host forraising
anti-murine dendritic cell mAbs.
Both of these problems seem to be reduced by immunizing a more phylogeneti-
cally distant species, the hamster. Hamsters have been used by others to raise the
first mAb to many murine molecules (9-11). In our two hamster anti-mouse den-
dritic cell fusions, anti-class II MHC mAbs were apparent, but their frequency was
about 10%. Furthermore, mAbs to new specificities were detected, particularly the
2E6 and N418 anti-integrins described here.
Besides hamster hosts, we also used the FACScan to screen hybridoma superna-
tants. This assay (Fig. 1) is more sensitive than microscopic fluorescence and re-
quires much smaller numbers of dendritic cells. By two-color analyses, we could
search for dendritic cell-reactive and -specific mAbs.
Tentative Identification of the 2E6 andN418 Epitopes as CD18 and CD11c.
￿
Initial im-
munoprecipitation experiments with 2E6 and N418 clearlyindicated that these mAbs
recognized members of the leukocyte integrin family. 2E6 immunoprecipitated the
well-characterized CD11a (LFA-1) and CDllb (CR3 receptor) heterodimers, whichMETLAY ET AL.
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are known(22, 23) to be the majorintegrinson lymphocytes and macrophages respec-
tively (Fig. 2). Moreover 2E6 blocked leukocyte adhesion events that are mediated
by these integrins. Although we were unable to blot the shared 90 kD CD18 integrin
a chain with 2E6, it seems likely that this chain carries the epitope. 2E6 and
anti-human CD18 mAbs both behave in an identicalfashionwith respect to the mol-
ecules recognized in immunoprecipitation and adhesion assays (27). Only a single
comparable reagent to 2E6, clone M18, has been reported in mice (22), but to our
knowledge this reagent has not been used subsequently.
The N418 mAb recognizes a distinct p150,90 heterodimer that is precipitated by
2E6 but not by anti-CDlla and CDllb (Fig. 3). Therefore, N418 likely recognizes
an epitope on the p150 a chain. Tentatively N418 is an anti-CD11c reagent since
CD11c is the only other known leukocyte integrin and in man has an apparent mo-
lecular mass of 150 kD. An alternative is that N418 recognizes a "CDlld" a chain,
but there is little evidence for a fourth type of leukocyte integrin.
The Tissue Distribution ofthe N418 Epitope.
￿
Lowlevels of CD11c are expressed on
human granulocytes and monocytes, and higher levels on macrophages that have
been cultured long term or observed in tissue sections (31, 32). However, the studies
in man have not addressed the question of CDllc on dendritic cells. We have yet
to see strong reactivity of N418 with mouse macrophages and granulocytes (manu-
script in preparation). For example, it reacts weakly or not at allwith cultured peri-
toneal macrophages or blood monocytes, with bone marrow granulocytes, or with
macrophage populations in tissue sections e.g., liverKupffercells and alveolar mac-
rophages (our unpublished observations). This could mean that human and mouse
CD11c have distinct tissue distributions, that dendritic cells express a novel form
of the CD11 integrins, or that N418 recognizes a dendritic cell-restricted epitope
on a p150 backbone that is shared with phagocytes.
Especially intriguing is the localization of N418+ cells in spleen. In T areas, N418
stained profiles that most likely are the interdigitating cells of these regions. Inter-
digitating cells are similar to isolated spleen dendritic cells in many respects (19,
25, 26), but it has been difficult to obtain mAbs like N418 that clearly react with
both dendritic populations and not with most other cell types. Anti-MHC class 11
reagents like N22 (Fig. 5, bottom) are in our hands the only reagents that strongly
stain isolated dendritic cells and can distinguish interdigitating cells from T lym-
phocytes in situ.
In addition to staining in the central region of the white pulp, N418 stained even
more intensely at the periphery of the white pulp nodule. We were able to show
that these foci of N418+ cells had few profiles with the markers of marginal zone
(24) and red pulp (19, 33) macrophages. The N418+ foci corresponded to regions
where arterial vessels andT cellsalso interrupted the marginal zone (Fig. 6). There-
fore, it would seem that most dendritic cells in spleen are largely concentrated in
regions whereT cells enter into the white pulp nodule. This would placetheseAPC
in aposition to select antigen-specific recirculatingTcells and/or to move more deeply
into the white pulp area.
TheDistinct Integrins ofSpleen Dendritic Cells.
￿
It is evident from this study that the
leukocyte integrins on mouse spleen dendritic cells are abundant and distinct from
other cells. While CD11a and CD11b can be detected on dendritic cells, the data
with the2E6and N418 mAbs indicate that the p150,90heterodimeris the most abun-1768
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dant leukocyte integrin on these cells. Therefore spleen dendritic cells differ from
most splenic lymphocytes and phagocytes which mainly express CD11a and CD11b,
respectively.
CD11c in man is not well characterized functionally. A recent report presents evi-
dence for a function in binding particles opsonized with C3bi (31). The CD11a and
CD11b molecules have known adhesion functions. CD11a contributes to the homo-
typic binding of lymphocytes (21), and to the heterotypic binding of T to B cells
(8) and of CTL to their targets (3). CD11b mediates the adhesion of phagocytes to
particles opsonized with C3bi (28) and otherligands (34-36), and to endothelium (37).
We therefore tested if N418 would block one key binding function of dendritic
cells, i.e., to T cells in the MLR. No block was observed. This could mean that N418
fails to recognize a functionaldomain needed for this binding. However, 2E6, which
recognizes all integrins including p150,90 and blocks CD11a and CD11b functions
including B-T cell clustering in the MLR, has little effect on dendriticT cell clustering.
Therefore, while leukocyte integrins can contribute to the function of dendriticT
cell clusters, they appear to do so after an initial CD11/18-independent binding event.
The failure of anti-CD11 and CD18 reagents to substantially reduce the initial
dendriticT cell clustering in a primary response like the MLR, perhaps is not sur-
prising. The function of leukocyte integrins is regulated not merely by expression
at the cell surface but by exposure to stimuli like PMA (20, 21) and other more phys-
iologic ligands (38, 39). Also, the known ligands ofthe integrins, ICAM-1 and ICAM-2,
are regulated at the level of expression but again by cytokines (40). Given the need
for "activation" of integrins and their ligands, how, one might ask, would molecules
like LFA-1 or ICAM be activated on a resting T cell, which is the cell the dendritic
cell must bind to initiate the immune response?
An alternative role for the p150 major dendritic cell integrin is suggested by the
work of Austyn et al. (26). They documented the capacity of spleen dendritic cells
to home to the T areas of lymphoid organs, possibly by an initial binding step to
the marginal zone region of spleen. p150,90 may function to guide dendritic cells
into the marginal zone and/or into the T area. This homing function may contribute
to the capacity of dendritic cells to initiate immune responses in situ (41). We are
designing experiments to test if the N418 mAb would block dendritic cell migration
and implicate p150,90 in their distinct homing properties.
Summary
Hybridoma fusions with hamster hosts were undertaken to generate mAbs to mouse
spleen dendritic cells. Two mAb were obtained and used to uncover the distinct inte-
grins of these AM One, 2E6, bound a determinant common to all members of
the CD11/CD18 family, most likely the shared 90 kD CD18 a chain. 2E6 immuno-
precipitated the characteristic ,Q2 integrin heterodimers from lymphocytes (p180,
90; CD11a) and macrophages (p170,90; CD11b), but from dendritic cells, a p150,90
(presumably CD11c) integrin was the predominant species. 2E6 inhibited the binding
function of the CD11a and CD11b integrins on B cells and macrophages in appro-
priate assays, but 2E6 exerted little or no inhibition on the clustering of dendritic
cells to T cells early in primary MLR, suggesting a CD11/CD18-independent mech-
anism for this binding. The second mAb, N418, precipitated a 150, 90 kD hetero-
dimer that shared the 2E6 CD18 epitope. This N418 epitope may be the murinehomologue of the previously characterized human CD11c molecule, but the epitope
was only detected on dendritic cells. N418 did not react with peritoneal macrophages,
anti-Ig-induced spleen B blasts, or bulk lymph node cells. When used to stain sec-
tions of spleen, N418 stained dendritic cells in the T-dependent areas, much like
anti-class 11 mAbs that were also generated in these fusions. In addition, N418 re-
vealed nests ofdendritic cells that punctuated the rim ofmarginal zone macrophages
between red and white pulp. This localization positioned most dendritic cells at regions
where arterial vessels and T cells enter the white pulp. We conclude that the p150,
90 heterodimer is the major 02 integrin of spleen dendritic cells, and we speculate
that it may function to localize these APC at sites that permit access to the recir-
culating pool of resting T cells.
We are grateful to Drs. M . Birkeland and E. Pure for help with the immunoprecipitations,
Dr. S. Wright for help with the CD11b binding assays, and Judy Adams for the art work
and photography.
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